Abstract: A stent comprises an elastically deformable stent wall forming a lumen extending between a first opening and a second opening of the stent. The stent wall is configured to be percutaneously delivered into a blood vessel, secure to a blood vessel wall of a blood vessel, and radially expand from a first configuration to a second configuration within the blood vessel into direct contact with the blood vessel wall. The first configuration defines a first major dimension, a first minor dimension, a first cross-sectional area, a first cross-sectional shape, and a first perimeter of the stent wall. The second configuration defines a second major dimension, a second minor dimension that is greater than the first minor dimension, a second cross-sectional area that is greater than the first cross-sectional area, and the first perimeter of the stent wall.

Abstract: An implantable glucose sensor includes: a housing, two injecting electrodes for injecting current into the tissue, two sensing electrodes for measuring impedance in the tissue, a coil within the housing for powering the sensor via a power source, a circuit board within the housing, the circuit board being electrically connected to the two sensing electrodes and the two injecting electrodes and the coil, and a communication unit for communicating data. The communication unit is connected to the circuit board. The two sensing electrodes and the two injecting electrodes are arranged on an outer surface of a first part of the housing. The outer surface of first part is of a convex shape. The two sensing electrodes and the two injecting electrodes are embedded in the convex shape so that they are flush with the outer surface of the convex shape.

Abstract: A disposable, self-contained electro-stimulation device configured with paired cutaneous electrodes for placement over specific acupuncture and neurostimulation points (such P6) on a patient's wrist, delivering controlled electrical pulses to reduce or prevent nausea and vomiting following surgery or anesthesia. Its advanced circuitry trades boost-converter efficiency for total system energy conservation, optimized for the low-duty-cycle pulse output used in neuromodulation rather than continuous high-power operation. Its single-IC, digitally controlled pulse engine performs both biphasic stimulation and contact verification, optimizing it for compact, battery-powered wearable medical devices. It also uses a miniature Hall-effect magnetic-field sensor positioned over a planar helical trace that carries the stimulation current, producing a proportional magnetic field detectable by the Hall sensor for the non-invasive current detection and skin-contact verification.

Abstract: Embodiments herein relate to medical device systems including features to enable secure wireless communications between components thereof. In an embodiment, a medical device system is included having an implantable medical device packaging unit and an implantable device. The implantable device can include a control circuit and a communications antenna. The implantable device can be configured to fit within the implantable medical device packaging unit prior to implantation in a patient. The system can also include a data bearing tag, wherein the data bearing tag is disposed on or in the implantable medical device packaging unit. In some embodiments the system can also include an external communication device. The external communication device can be configured to receive data from the data bearing tag enabling secure wireless communications between the implantable device and the external communication device. Other embodiments are also included herein.

Abstract: Systems and methods are provided for applying electrical stimulation to a body by an electrode spaced from a target nerve of passage. It has been discovered that pain felt, or perceived to be felt, in a given region of the body can be treated by stimulating muscle close to a “nerve of passage” in a region that is superior (i.e., cranial or upstream toward the spinal column) to the region where pain is felt, such as in a case of post-amputation residual limb pain, or purportedly felt in the case of post-amputation phantom limb pain.

Abstract: An insertion tool having a wall of tubular or funneled shape, with, on a front portion thereof, a front side opening so that an opening of an empty pouch for an implantable pulse generator, and corresponding wiring, can be shifted onto the front portion and over the front side opening, and with, on a back portion of the insertion tool, a backside opening so that an implantable pulse generator, and corresponding wiring, can be inserted through that backside opening, through a passageway opening to the front side opening and into the pouch, while manually holding the insertion tool using the back portion The wall has an axial slot between the front side opening and the backside opening.

Abstract: The disclosed technology includes an electrode for a medical probe having an elongated body. At least a portion of the elongated body can be electrically conductive. The elongated body can define a lumen that extends through the elongated body along a longitudinal axis of the elongated body. The electrode can include a locking stub that extends at least partially into the lumen so that the locking stub is locked to a member inserted into the lumen.

Abstract: A medical implant includes an implant component configured to be implanted in a patient, an electrode array, an energy storage device, and a power management unit. The electrode array includes at least two electrodes spaced apart on the implant component. The energy storage device and power management unit are inside the implant component. The power management unit is operative to control electrical stimulation of the electrode array by current supplied by the energy storage device to be at a level which at least reduces formation of a biofilm on at least part of the implant component while implanted in the patient.

Abstract: Systems and methods which provide retractable anchor configurations for medical device leads are described. A retractable anchor may implement a retractable distention composed of a resilient material. The retractable distention may be distended when in a neutral state and may be contracted when in a biased state. A biasing bulkhead may be configured to receive a bias force sufficient to retract the retractable distention. A stylet may be inserted into an axial lumen of a medical device lead having retractable tip anchor structure and may engage the biasing bulkhead to apply a bias force. A stylet knob may be configured to interface with the stylet and provide bias force to be transferred to the biasing bulkhead of the retractable tip anchor structure. Locking the stylet knob on the medical device lead may maintain the bias force applied to the biasing bulkhead until the stylet knob is unlocked.

Abstract: Device surfaces are rendered superhydrophobic and/or superoleophobic through microstructures and/or nanostructures that utilize the same base material(s) as the device itself without the need for coatings made from different materials or substances. A medical device includes a portion made from a base material having a surface adapted for contact with biological material, and wherein the surface is modified to become superhydrophobic, superoleophobic, or both, using only the base material, excluding non-material coatings. The surface may be modified using a subtractive process, an additive process, or a combination thereof. The product of the process may form part of an implantable device or a medical instrument, including a medical device or instrument associated with an intraocular procedure.

Abstract: A burr hole device is configured to receive a catheter and a cable of a sheath. The sheath is configured to receive a portion of the catheter and has an electrode. When the catheter and sheath are implanted with the burr hole device, the catheter and electrode of the sheath are implanted in a brain. Systems and apparatuses may include the burr hole device and/or a cranial port device, the catheter, and the sheath.

Abstract: A method for circumscribing an insulating barrier region around a singular conductive microneedle structure or plurality of conductive microneedle structures adhered to a fixed substrate for the purpose of spatially defining a conduit for the routing of an electrical signal from the surface of said microneedle or microneedles to the posterior surface of the substrate is disclosed herein. A microneedle-based electrochemical biosensors structure comprises a substrate, a microneedle biosensor, a primary electrically conductive element, a secondary electrically conductive element and an electrically insulative annular barrier.

Abstract: Endovascular lead design and delivery systems are described herein. One variation of an endovascular lead apparatus may generally comprise an elongate body having a proximal portion and a distal portion, one or more electrodes positioned along a first side of the distal portion, a tray positioned along a second side of the distal portion opposite to the first side, and one or more frame members positioned along the tray and which are reconfigurable from a low-profile delivery configuration to an expanded deployed configuration, wherein expansion of the one or more frame members to the expanded deployed configuration reconfigures the distal portion into contact against a tissue wall for energy delivery via the one or more electrodes.

Abstract: A neuromodulation device comprises stimulus electrodes and sense electrodes. A stimulus source provides stimuli to evoke a neural response on a neural pathway. A signal sensed at the sense electrodes includes an evoked neural response. A control unit controls the stimulus source to provide the neural stimulus according to a stimulus intensity parameter; measures an intensity of the evoked response; and completes a feedback loop using the measured intensity and controller parameters to control the stimulus intensity parameter to maintain the measured intensity at a target value. Optimal values of the controller parameters are determined from a representative value of a characteristic of the feedback loop, the representative value having been derived from data of previously programmed patients, and/or the processor is configured to determine optimal values of the one or more controller parameters from a predetermined value of an amplification parameter of the feedback loop.

Abstract: A shock wave catheter includes an elongate member and a shock wave emitter assembly located at a distal region of the elongate member. The shock wave emitter assembly includes a shock absorber made of a low durometer material. A shock wave catheter system includes a shock wave catheter with a shock absorber and a high voltage power supply configured to generate high voltage pulses. A method for treating a lesion in a body lumen includes generating shock waves with a shock wave catheter system that includes a shock wave catheter with a shock absorber.

Abstract: A lead for an implantable medical device (IMD) includes an electrode having a plurality of brick segments that are discrete and mechanically connected to one another in a line. The brick segments are electrically conductive and electrically connected to one another. The brick segments are configured to be powered by a pulse generator of the IMD to deliver high-voltage shocks for defibrillation therapy.

Abstract: The present disclosure provides a transcutaneous energy transfer system (TETS), having an implantable receiving coil in communication with an implantable controller and a hermetically sealed package encased by the implantable receiving coil. The hermetically sealed package including a plurality of tuning capacitors, at least one temperature sensor, scavenging circuitry configured to scavenge power from the plurality of tuning capacitors, and a temperature measuring circuit in communication with the at least one temperature sensor and the scavenging circuitry. The at least one temperature sensor being configured to measure a temperature of the hermetically sealed package and the temperature measuring circuit being configured to transmit the measured temperature to the implantable controller.

Abstract: In one aspect, the present disclosure provides organic semiconductors (OSNTs) as well as high-performance electrochemical devices based on the present OSNTs for the production of micro and nano-scale actuators. The present OSNTs may be used in several applications, including movable and implantable interface devices, such as flexible neural microelectrodes. Also provided herein are flexible neural microelectrodes based on conjugated polymer actuators.

Abstract: The present invention relates to an ablation assembly to treat target regions of a tissue in organs comprising: an ablation catheter comprising an elongate shaft having a longitudinal main direction (X-X), said elongate shaft comprising at least a shaft distal portion, said shaft distal portion comprising a shaft distal portion distal end; said ablation catheter comprising an inner lumen arranged within the elongate shaft; said ablation catheter comprising a shaft ablation assembly fixedly disposed at said shaft distal portion, the shaft ablation assembly being configured to deliver both thermal energy for ablating said tissue and non-thermal energy for treating said tissue; at least a shape setting mandrel disposed within the ablation catheter, the shape setting mandrel being insertable within the inner lumen and removable from the inner lumen, wherein the shape setting mandrel is free to move in respect of the inner lumen avoiding any constraint with said shaft distal portion during the shape setting

Abstract: An AMD has a main housing closed by an end cap. A PCB supports electrical contacts connected to electronic components. An electrical power source powers the electronic components. A metallic sleeve connected to an inner surface of the end cap has a sleeve lumen aligned with a cap lead opening. A terminal housing assembly has a number of insulator rings connected to a number of the metallic terminal housings in an alternating sequence extending distally from the sleeve. The insulator rings support silicone ring seals and the terminal housings support canted coil springs. Jumper wires connect the terminal housings of the terminal housing assembly to the electrical contacts of the PCB without an intermediate feedthrough. In use, the electrical contacts of a lead are moved through the sleeve lumen and into the terminal housing assembly to connect the electrical contacts to the canted coil springs of the terminal housings.

Abstract: A low-profile cranial device is adapted for covering and protecting electrical leads. The cranial device includes a static cranial implant shaped and dimensioned for housing a functional neurosurgical implant including electrical leads. The static cranial implant includes an outer first surface along an exterior side of the static cranial implant, an inner second surface along an interior side of the static cranial implant, and a peripheral wall extending between the outer first surface and the inner second surface. A cavity is formed along the outer first surface of the static cranial implant, the cavity being shaped and dimensioned to house the functional neurosurgical implant in a manner allowing the electrical leads to be wound up to store excess electrical lead length.

Abstract: An implantable pulse generator (IPG) including a case containing an energy storage device and one or more electrode leads. A header is coupled to the case. The header includes a cassette, an antenna coupled to the cassette and electrically coupled to the case, the case configured as a part of the antenna for receiving and transmitting electromagnetic signals, and an electrode attachment structure configured to couple with the cassette and configured to couple with the one or more electrode leads.

Abstract: A medical device comprising a tube, a first electrode and a second electrode, and a structure at a distal portion of the tube, the structure defining a first section and a second section, wherein the first and second sections are configured to be filled with a conductive medium, wherein the first electrode is contained within the first section, and the second electrode is contained within the second section, and wherein the structure includes a central barrier separating the first section from the second section, and the central barrier is insulative.

Abstract: A system includes a lead with a balloon, wherein the lead defines an inflation lumen in fluid communication with the balloon. The system further includes an implantable medical device with a housing defining a fastener opening and a lead lumen. The lead lumen is configured to receive a proximal portion of the lead. The system further includes a fastener defining a fastener lumen. The fastener is configured to engage the fastener opening and the proximal portion of the lead to retain the proximal portion within the lead lumen. The fastener lumen is in fluid communication with the lead lumen and the inflation lumen, such that a pump in fluid communication with the fastener lumen inflates the balloon when the proximal portion of the lead is within the lead lumen.

Abstract: An apparatus includes a shaft and an end effector at a distal end of the shaft. The end effector has a distal end and a proximal end with a longitudinal intermediate point between the distal and proximal ends. The end effector is sized to fit in an anatomical passageway within a cardiovascular system. The end effector includes at least one sensor electrode and a reference electrode. The at least one sensor electrode is configured to contact cardiovascular tissue and thereby pick up potentials. The reference electrode is configured to pick up a potential from fluid in contact with the reference electrode. The reference electrode is located proximal to the longitudinal intermediate point of the end effector. The end effector is configured to prevent the reference electrode from contacting tissue.

Abstract: A neurostimulator implant is provided that includes a circuitry unit having first and second ends, a conducting side, and an opposing side. First and second electrodes are disposed on an outer surface of the circuitry unit so as to circumscribe the circuitry unit. Circuitry is disposed within the circuitry unit. An insulating member is disposed on the opposing side of the circuitry unit such that, on the opposing side, each electrode is covered by the insulating member by being sandwiched between a first side of the insulating member and the circuitry unit, such that the insulating member inhibits electrical conduction from the electrodes into tissue of a subject. A second side of the insulating member, opposite the first side, defines a generally flat side of the implant facing away from the first and the second electrodes of the circuitry unit. Other embodiments are also described.

Abstract: A cerebral spinal fluid shunt plug includes a shunt plug housing having a shunt valve recess formed therein and a window recess with an access hole. The cerebral spinal fluid shunt plug also includes a shunt valve shaped and dimensioned for positioning within the shunt valve recess of the shunt plug housing and a lucent disk shaped and dimensioned for the passage through the central access hole of the shunt plug housing. In another embodiment, a cerebral spinal fluid shunt plug includes a shunt plug housing having a shunt valve recess formed therein and an intracranial monitoring device recess with an access hole. A shunt valve is positioned within the shunt valve recess of the shunt plug housing and an intracranial monitoring device is passed through the central access hole of the shunt plug housing.

Abstract: The present disclosure is directed a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method may include providing a first intravascular device having a distal portion and at least one aperture and positioning the distal portion of the first intravascular device in the vascular wall. The method may further include providing a reentry device having a body and a distal tip, the distal tip having a natural state and a compressed state and inserting the distal tip, in the compressed state, in the distal portion of the first intravascular device. The method may further include advancing the distal tip, in the natural state, through the at least one aperture of the first intravascular device.

Abstract: A novel delivery system for implantation of a cardiac pacing lead comprising an elongated delivery sheath sized to accept the cardiac pacing lead inside thereof and an electrically-active elongated stylet positioned along the cardiac pacing lead and having a first distal electrode configured to provide a first electrical connection to the proximal end of the elongated stylet. The implantation method includes a step of pre-checking a first position in the cardiac tissue by temporarily confirming the ability to deliver the pacing therapy at that position using the first distal electrode of the elongated stylet. If the first position is determined to be acceptable, the cardiac pacing lead is implanted at that position. Otherwise, the delivery system is moved to another position without any significant trauma to the cardiac tissue at the first position.

Abstract: An electromagnetic tracking sensor for use in a medical device includes a flexible hollow cylinder core having an interior surface and an exterior surface. The flexible hollow cylinder core has a magnetic material layer attached to the interior surface of the flexible hollow cylinder core. A wire coil is adjacent to, and circumferentially surrounds, the exterior surface of the flexible hollow cylinder core.

Abstract: A system includes memory configured to store image content representative of a lead implanted within a patient, and processing circuitry. The processing circuitry is configured to determine a reference point in the image content, determine a plane in the image content that corresponds to an orientation marker based on the reference point, determine an orientation of the lead based on the determined plane, and output information indicative of the determined orientation.

Abstract: An external control device, neuromodulation system, and method of providing therapy to a patient using an implantable neuromodulator implanted within the patient. Electrical modulation energy is delivered from the neuromodulator to the patient in accordance with the pre-existing modulation program when in one of the super-threshold delivery mode and the sub-threshold delivery mode. Operation of the neuromodulator is switched to the other of the super-threshold delivery mode and the sub-threshold delivery mode. A new modulation program may be derived from a pre-existing modulation program, and the neuromodulator may deliver the electrical modulation energy to the patient in accordance with the pre-existing modulation program during the other of the super-threshold delivery mode and the sub-threshold delivery mode.

Abstract: Winding a wire at a first location such that the wire is bunched at the first location, extending the wire from the first location to a second location, winding the wire at the second location such that the wire is bunched at the second location, extending the wire from the second location back towards the first location to a third location proximate the second location, winding the wire at the third location such that the wire is bunched at the third location, extending the wire from the third location back towards the first location to a fourth location at least proximate the first location, winding the wire at the fourth location such that the wire is bunched at the fourth location, severing the wire at one or more locations, and forming an electrode assembly utilizing the windings.

Abstract: Embodiments described relate to a medical device including an invasive probe that, when inserted into an animal (e.g., a human or non-human animal, including a human or non-human mammal), may aid in diagnosing and/or treating a lesion of the animal (e.g., a growth or deposit within vasculature that fully or partially blocks the vasculature). The invasive probe may have one or more sensors to sense characteristics of the lesion, including by detecting one or more characteristics of tissues and/or biological materials of the lesion. The medical device may be configured to analyze the characteristics of a lesion and, based on the analysis, provide treatment recommendations to a clinician. Such treatment recommendations may include a manner in which to treat a lesion, such as which treatment to use to treat a lesion and/or a manner in which to use a treatment device.

Abstract: A catheter apparatus can include a first magnet coupled to a catheter and a second magnet configured to couple to a patient's skin. When the catheter and the first magnet are positioned within a patient's body, the second magnet can exert a magnetic force on the first magnet that stabilizes the catheter relative to the second magnet. The second magnet can be directly attached to the patient's skin or secondary devices such as straps can be used to place the second magnet in a fixed position relative to the patient's body. In some implementations, a plurality of magnets can facilitate holding the catheter in a substantially fixed position within the patient.

Abstract: Sampling or removing interstitial fluid of a subject using an implantable access chamber and associated methods of use. An implantable access chamber can be configured to be inserted into tissue of a subject. The implantable access chamber can comprise a sensor arranged therein, wherein the sensor is configured to sense at least one analyte of interstitial fluid of the subject. The implantable access chamber can include a barrier portion defining a cavity. The barrier portion may be a material permeable to the interstitial fluid and occlusive to cells of the subject.

Abstract: The present disclosure relates to a device for applying electrical stimulation to biological tissues. Specifically, the present disclosure is related to a device for applying anodal/cathodal biphasic electrical stimulation to beta cells of the pancreas. Through application of biphasic stimulation to beta cells of the pancreas, insulin secretion can be increased in an effort to overcome deficiencies associated with diabetic patients.

Abstract: Systems and methods for high-bandwidth, minimally invasive brain-computer interfaces (BCIs) are disclosed. The BCIs are configured for deployment and operation in conjunction with a comprehensive interventional electrophysiology procedural suite. Three primary methods of minimally invasive electrode array delivery are disclosed: (1) cortical surface delivery, (2) ventricular delivery, and (3) endovascular delivery. Additionally, systems and methods for interacting with such high-bandwidth electrode arrays are discussed, including real-time imaging, signal processing, and neural decoding. Systems and methods for architectures for accelerating the underlying computational processes (such as graphics processing units or tensor processing units) are also discussed. Multiple applications of BCIs are discussed, with emphasis on restoration, rehabilitation, and augmentation of neurologic function.

Abstract: Systems and methods for high-bandwidth, minimally invasive brain-computer interfaces (BCIs) are disclosed. The BCIs are configured for deployment and operation in conjunction with a comprehensive interventional electrophysiology procedural suite. Three primary methods of minimally invasive electrode array delivery are disclosed: (1) cortical surface delivery, (2) ventricular delivery, and (3) endovascular delivery. Additionally, systems and methods for interacting with such high-bandwidth electrode arrays are discussed, including real-time imaging, signal processing, and neural decoding. Systems and methods for architectures for accelerating the underlying computational processes (such as graphics processing units or tensor processing units) are also discussed. Multiple applications of BCIs are discussed, with emphasis on restoration, rehabilitation, and augmentation of neurologic function.

Abstract: This disclosure is directed to devices, systems, and techniques for controlling electrical stimulation. In some examples, a computing device includes a therapy-management application configured to assist a user to: capture a representative evoked compound action potential (ECAP) signal from a patient based; apply one or more filters to the representative ECAP signal to select one or more parameters of the representative ECAP signal; and control electrical stimulation therapy based at least in part on the one or more parameters.

Abstract: An electronic system for multimodal diagnostic measurements and therapeutic interventions includes a plurality of element network layers vertically stacked one with another on a flexible substrate, each element network layer being bi-axially stretchable and comprising a plurality of elements configured in an addressable, interconnected array formed in a multilayered structure and operably performing a distinct function. The electronic system is a multimodal, multiplexed soft electronic system in a multilayered configuration that supports capabilities ranging from high-density spatiotemporal mapping of temperature, pressure and electrophysiological parameters, to options in programmable high-density actuation of thermal inputs and/or electrical stimulation, drug elution, radio frequency ablation, and/or irreversible electroporation ablation.

Abstract: An electrotherapeutic device includes a stimulation member and an anchor to retain the stimulation member at the treatment site of implantation. The stimulating member and the anchor have surfaces that are “keyed” to each other, such that when the stimulating member is inserted in the anchor, the stimulating member is resistant to moving relative to the anchor. The anchor also includes one or more retaining channels, which are configured to receive sutures therein that are used to secure the anchor to the treatment site of implantation, which prevent the anchor from moving or migrating relative to the treatment site.

Abstract: A biocompatible medical device can be at least partially implantable into a living human or animal subject to provide active treatment of biofilm that can occur use within the subject. The medical device can include a catheter, including an interior conduit capable of permitting fluid flow. A heating device can be located on a portion of the catheter to be located within the subject, the heating device including at least a pair of electrodes having a variable spacing therebetween, the variable spacing specified to allow heat to be generated using a time-varying electromagnetic input signal providing a variable frequency to control a variable location along the electrodes at which heat is generated, such as can provide a virtual matrix of local heat sources.

Abstract: A physiological signal monitoring device includes a sensing member and a transmitter connected to the sensing member and including a circuit board that has electrical contacts, and a connecting port, which includes a socket communicated to the circuit board and a plurality of steel balls. The sensing member is removably inserted into the socket. The steel balls are electrically connected to the electrical contacts and the sensing member for enabling electric connection therebetween. Each of the steel balls is frictionally rotated by the sensing member during insertion of the sensing member into the socket and removal of the sensing member from the socket.

Abstract: An implantable device has a hermetically sealed enclosure, an electronic device within the hermetically sealed enclosure, and a plurality of feedthrough conductors in mechanical contact with the hermetically sealed enclosure and exposed outside of the hermetically sealed enclosure. The implantable device also has a flexible substrate with a plurality of therapy contacts, and a plurality of continuously conductive elements extending along the flexible substrate from the array of therapy contacts and terminating at a plurality of connection pads. Each of the continuously conductive element is integral with at least one therapy contact and at least one connection pad to electrically communicate the noted therapy contact(s) and the noted connection pad(s). The thickness of each continuously conductive element may be between about 5 and 190 microns. The implantable device also has a plurality of mechanical welded couplings that each couple at least one of the connection pads.

Abstract: Devices, systems and techniques are provided to facilitate chronic monitoring of biological signals. An implant device can include a set of branch portions. Each branch portion can include multiple electrodes disposed on a bottom surface and can have vias that connect the electrode to a trace on the top of the branch portion. Each branch portion can include a hole through which a connector (e.g., suture) can be pulled. The connector can also be threaded through a hole in a curved arm of an implantation tool, To implant the implant device, the implantation tool can be inserted through an incision, moved to a target location and stabilized. An end of the connector can then be pulled, which can cause the implant device to move to the target location. The implant device can then be stabilized and the implantation tool explanted.

Abstract: A method of treating heart disease in a subject includes percutaneously introducing a catheter into vasculature of the subject. The catheter may include a neuromodulation element. The neuromodulation element may be positioned on an expansion element. The neuromodulation element of the catheter can be positioned in a subclavian artery of the subject. The catheter can be used to electrically stimulate at least one of a dorsal subclavian ansae or a ventral subclavian ansae. The method can include confirming stimulation of the dorsal subclavian ansae and/or the ventral subclavian ansae by monitoring a cardiac parameter. After confirming stimulation of the dorsal subclavian ansae and/or the ventral subclavian ansae, ablation energy can be provided to the dorsal subclavian ansae and/or the ventral subclavian ansae.

Abstract: Disclosed are a connection device for a neurostimulator, a kit for a neurostimulator, including same, a neurostimulator lead using same, and an extension cable connection method, the connection device encompassing a connection part for connecting, with an extension cable, the lead of neurostimulator such as a spinal cord stimulator, or an electrode of the lead, wherein the connection device comprises a body and a magnifier, on at least one side of the body, that can magnify the connection part. Therefore, a very complicated process and the time of combining, with a connection cable, the lead of a neurostimulator such as a spinal cord stimulator, or an electrode of the lead can be reduced, and practitioner convenience can be increased.

Abstract: A biological information monitoring system includes: a biological information monitoring apparatus that monitors biological information of an organism wearing the biological information monitoring apparatus on an ear.

Abstract: A power control circuit for use with devices that will be placed in a flammable sterilizing gas includes a bi-stable switch that is configured to produce an output to place the circuitry of a connected device in a run state or a sleep state. The bi-stable switch controls one or more transistors to drain energy from energy storage devices in the circuitry of the connected device to a level below an ignition level of a sterilizing gas. A remotely actuatable switch can be actuated from outside of a packaging in which the power control circuit is placed to cause the bi-stable switch to produce an output that puts the circuitry in the run state without removing the power control circuit from the packaging.